|
|
|
|
|
Topics
|
|
Glioblastoma
| Treatment | Targeted therapy | Overview
|
|
|
|
|
|
Home
> Publications
> Topics
> Glioblastoma
>
Treatment
>
Targeted
therapy >
Overview
|
|
|
|
|
|
Shikalov A, Koman I, Kogan NM.
Targeted
Glioma Therapy-Clinical Trials and Future
Directions.
Pharmaceutics.
2024 Jan 11;16(1):100. doi:
10.3390/pharmaceutics16010100. PMID:
38258110. Review. ˍ
|
|
|
|
Jacome MA, Wu Q, Piña Y, Etame AB.
Evolution
of Molecular Biomarkers and Precision Molecular Therapeutic
Strategies in Glioblastoma.
Cancers
(Basel). 2024 Oct 29;16(21):3635. doi:
10.3390/cancers16213635. PMID:
39518074. Review. ˍ
|
|
|
|
Satish S, Athavale M, Kharkar PS.
Targeted
therapies for Glioblastoma multiforme (GBM): State-of-the-art and
future prospects.
Drug
Dev Res. 2024 Nov 1;85(7):e22261. doi:
10.1002/ddr.22261. PMID:
39485272. Review˰ ˍ
|
|
|
|
Rusak A, Wiatrak B, Krawczyńska K, Górnicki T,
Zagórski K, Zadka Ł, Fortuna W.
Starting
points for the development of new targeted therapies for
glioblastoma multiforme.
Transl
Oncol. 2024 Nov 11;51:102187. doi:
10.1016/j.tranon.2024.102187. PMID:
39531784. Review. ˍ
|
|
|
|
Ippen FM, Scherm A, Kessler T, Hau P, Agkatsev S, Baurecht H, Wick
W, Knüttel H, Leitzmann MF, Seliger-Behme C.
Targeted
agents in patients with progressive glioblastoma-A systematic
meta-analysis of randomized clinical trials.
Cancer
Med. 2024 Jun 21;13(12):e7362. doi:
10.1002/cam4.7362. PMID:
39618405. Meta-analysis. ˍ
|
|
|
|
Singh G, Rohit, Kumar P, Aran KR.
Targeting
EGFR and PI3K/mTOR pathways in glioblastoma: innovative
therapeutic approaches.
Med
Oncol. 2025 Mar 10;42(4):97. doi:
10.1007/s12032-025-02652-1. PMID:
40064710. Review˰ ˍ
|
|
|
|
*Tang J, Karbhari N, Campian JL.
Therapeutic
Targets in Glioblastoma: Molecular Pathways, Emerging Strategies,
and Future Directions.
Cells.
2025 Mar 26;14(7):494. doi:
10.3390/cells14070494. PMID:
40214448. Review. ˍ
|
|
|
|
|
|
|